A longitudinal study of 155 lymphoma patients found that older adults recovered memory function after CAR T-cell therapy ...
MedPage Today on MSN
A deep dive into double-hit lymphoma
The rare and aggressive DLBCL subtype has a traditionally poor prognosis ...
In a phase 1 trial, CD19/CD20/CD22 CAR T cells produced complete responses in 83% of patients with relapsed/refractory B-cell ...
A controlled syngeneic mouse study found that intracranial A20 B-cell lymphoma had stronger T-cell exhaustion, regulatory-cell expansion and dendritic-cell immunoregulation than subcutaneous tumors.
Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During their preparation for this battle, B cells transiently revert to a more ...
Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During their preparation for this battle, B cells transiently revert to a more ...
About 30 percent of all non-Hodgkin lymphoma diagnoses in the United States are DLBCL. Although it is an aggressive cancer that can spread quickly, it is treatable. These can be symptoms of many ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results